{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:43:54Z","timestamp":1772721834431,"version":"3.50.1"},"reference-count":43,"publisher":"Tech Science Press","issue":"2","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2024.047698","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T07:04:30Z","timestamp":1717484670000},"page":"407-420","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Circular RNA circAGAP1 promotes sunitinib sensitivity in renal cell carcinoma via sponging multiple PDGFR-targeted miRNAs"],"prefix":"10.32604","volume":"33","author":[{"given":"YI","family":"HONG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIANYI","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUANG","family":"QIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SAIFEI","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUTING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAOHUA","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QI","family":"LV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PEIJUN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GANGMIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUNHUI","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding pathologic variants of renal cell carcinoma","volume":"67","author":"Shuch","year":"2015","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European association of urology guidelines on renal cell carcinoma","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and male genital organs\u2013part A","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00345-016-1773-y","article-title":"Renal cell carcinoma recurrences and metastases in primary non-metastatic patients","volume":"34","author":"Dabestani","year":"2016","journal-title":"World J Urol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41571-019-0209-1","article-title":"Towards individualized therapy for metastatic renal cell carcinoma","volume":"16","author":"Kotecha","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ctrv.2016.09.002","article-title":"Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy","volume":"50","author":"Calvo","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"100929","DOI":"10.1016\/j.drup.2023.100929","article-title":"Sunitinib resistance in renal cell carcinoma","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist Updat"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejca.2013.08.021","article-title":"Sunitinib objective response in metastatic renal cell carcinoma","volume":"50","author":"Molina","year":"2014","journal-title":"Eur J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-17-1299","article-title":"Resistance to systemic therapies in clear cell renal cell carcinoma","volume":"17","author":"Makhov","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-023-01766-2","article-title":"The function and mechanisms of action of circular RNAs in Urologic Cancer","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/15548627.2019.1634945","article-title":"Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA\/AMPK\u03b1 signaling in STK11 mutant lung cancer","volume":"16","author":"Chen","year":"2020","journal-title":"Autophagy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","article-title":"Exosomal circRNA","volume":"16","author":"Zhang","year":"2023","journal-title":"J Hematol Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-cellbio-120420-125117","article-title":"Biogenesis and regulatory roles of circular RNAs","volume":"38","author":"Yang","year":"2022","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.drup.2023.100937","article-title":"Exosomal circular RNAs","volume":"67","author":"Guo","year":"2023","journal-title":"Drug Resist Updat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","article-title":"Exosome-derived circCCAR1 promotes CD8+ T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2023","journal-title":"Mol Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","article-title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR","volume":"15","author":"Wang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-22-0991","article-title":"CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin chemoresistance by facilitating YBX1 nuclear localization","volume":"28","author":"Hong","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/s41388-022-02386-8","article-title":"CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","article-title":"Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis","volume":"37","author":"Hanniford","year":"2020","journal-title":"Cancer Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-022-01586-w","article-title":"The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p\/CARM1 axis","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.7150\/jca.48770","article-title":"Circular RNA microarray expression profile and potential function of circ0005875 in clear cell renal cell carcinoma","volume":"11","author":"Lv","year":"2020","journal-title":"J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-021-01864-3","article-title":"CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma","volume":"40","author":"Lv","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3322\/caac.21411","article-title":"Treatment of renal cell carcinoma","volume":"67","author":"Barata","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2021.10.003","article-title":"Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184\/GPCPD1\/lysophosphatidic acid axis","volume":"523","author":"Huang","year":"2021","journal-title":"Cancer Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","article-title":"N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating \u03b2-catenin signaling","volume":"19","author":"Xu","year":"2020","journal-title":"Mol Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ymthe.2019.05.011","article-title":"circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p\/FOXO3a axis in breast cancer","volume":"27","author":"Sang","year":"2019","journal-title":"Mol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"216023","DOI":"10.1016\/j.canlet.2022.216023","article-title":"CircPTK2\/PABPC1\/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer","volume":"554","author":"Meng","year":"2023","journal-title":"Cancer Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.32604\/or.2023.030611","article-title":"CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149\/UCP2 pathway","volume":"31","author":"Du","year":"2024","journal-title":"Oncol Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.32604\/or.2022.027534","article-title":"CircMAN1A2 promotes vasculogenic mimicry of nasopharyngeal carcinoma cells through upregulating ERBB2 via sponging miR-940","volume":"30","author":"Mo","year":"2024","journal-title":"Oncol Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-019-1125-9","article-title":"Roles of circRNAs in the tumour microenvironment","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/mt.2015.129","article-title":"miR-221\/222 are involved in response to sunitinib treatment in metastatic renal cell carcinoma","volume":"23","author":"Khella","year":"2015","journal-title":"Mol Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12951-024-02295-w","article-title":"CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination","volume":"22","author":"Zhu","year":"2024","journal-title":"J Nanobiotech"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.actbio.2022.08.067","volume":"152","author":"Ning","year":"2022","journal-title":"Acta Biomater"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1007\/s12274-022-5002-2","article-title":"Recent advances of bioresponsive polymeric nanomedicine for cancer therapy","volume":"16","author":"Hong","year":"2023","journal-title":"Nano Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"9715","DOI":"10.1007\/s12274-023-5550-0","article-title":"Nanotopographic micro-nano forces finely tune the conformation of macrophage mechanosensitive membrane protein integrin \u03b22 to manipulate inflammatory responses","volume":"16","author":"Guo","year":"2023","journal-title":"Nano Res"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/file.techscience.com\/files\/or\/2025\/TSP_OR-33-2\/OncolRes-33-02-47698\/OncolRes-33-47698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:16:30Z","timestamp":1741331790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n2\/59296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.047698","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"2023-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-16","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}